You are here
Purchase of Salix adds gastrointestinal drugs to Valeant stable
VALEANT Pharmaceuticals International Inc agreed to buy Salix Pharmaceuticals Ltd for about US$10.1 billion, a person with knowledge of the matter said, to add gastrointestinal drugs to its stable of offerings.
Valeant will pay US$158 a share in cash for Salix, the person
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org